Literature DB >> 12807485

Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell.

Charlotta Tenger1, Xinghua Zhou.   

Abstract

Apolipoprotein E (ApoE) is synthesized by a variety of cells including macrophages. These cells activate T lymphocytes by antigen presentation, while the T-cell cytokine, interferon-gamma, inhibits macrophage ApoE expression. ApoE inhibits T-cell proliferation in culture but its role in immune responses has been unclear. The ApoE-deficient (E0) mouse permits an evaluation of the immunological role of ApoE. We have analysed T-cell responses to an exogenous antigen (ovalbumin) and polyclonal mitogen (concanavalin A) in E0 and ApoE+/+ mice. Macrophages of E0 mice stimulated T-cell activation more effectively as antigen-presenting cells than macrophages from ApoE+/+ mice. Both proliferation and interferon-gamma secretion were enhanced in T cells activated in the context of antigen-presenting cells from E0 mice. Since the macrophage-T-cell interaction depends on interactions between cell surface molecules, we assessed the expression of such molecules after in vivo stimulation with interferon-gamma. This treatment caused an increased expression of the co-stimulatory surface proteins CD40 and CD80, and also of the major histocompatibility complex class II molecules I-Ab on macrophages of E0 mice compared with ApoE+/+. Our data suggest that ApoE inhibits T-cell activation by reducing the density of immune stimulatory proteins on antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807485      PMCID: PMC1782975          DOI: 10.1046/j.1365-2567.2003.01665.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation.

Authors:  L K Curtiss; T M Forte; P A Davis
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

Review 2.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

3.  Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.

Authors:  J A Cuthbert; P E Lipsky
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

4.  Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages.

Authors:  S K Basu; J L Goldstein; M S Brown
Journal:  Science       Date:  1983-02-18       Impact factor: 47.728

5.  Suppression of lymphocyte activation by plasma lipoproteins.

Authors:  M Macy; Y Okano; A D Cardin; E M Avila; J A Harmony
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

6.  Immunoregulation by low density lipoproteins in man: low density lipoprotein inhibits mitogen-stimulated human lymphocyte proliferation after initial activation.

Authors:  J A Cuthbert; P E Lipsky
Journal:  J Lipid Res       Date:  1983-11       Impact factor: 5.922

7.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

8.  The phosphatidylinositol response and proliferation of oxidative enzyme-activated human T lymphocytes: suppression by plasma lipoproteins.

Authors:  A L Akeson; D W Scupham; J A Harmony
Journal:  J Lipid Res       Date:  1984-11       Impact factor: 5.922

9.  Modulation of apoprotein E secretion in response to receptor-mediated endocytosis in resident and inflammatory macrophages.

Authors:  R Takemura; Z Werb
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

10.  Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes.

Authors:  Z Werb; J R Chin
Journal:  J Cell Biol       Date:  1983-10       Impact factor: 10.539

View more
  40 in total

Review 1.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease.

Authors:  Dominika Nackiewicz; Paromita Dey; Barbara Szczerba; Saleh Mohammad; Jennifer L Kaplan; Coleen A McNamara; Umesh S Deshmukh; Harini Bagavant
Journal:  Nephron Exp Nephrol       Date:  2014-05-16

Review 3.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

Review 4.  Impact of environmental factors on alloimmunity and transplant fate.

Authors:  Leonardo V Riella; Jessamyn Bagley; John Iacomini; Maria-Luisa Alegre
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

5.  Apolipoprotein E4 domain interaction accelerates diet-induced atherosclerosis in hypomorphic Arg-61 apoe mice.

Authors:  Delphine Eberlé; Roy Y Kim; Fu Sang Luk; Nabora Soledad Reyes de Mochel; Nathalie Gaudreault; Victor R Olivas; Nikit Kumar; Jessica M Posada; Andrew C Birkeland; Joseph H Rapp; Robert L Raffai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-22       Impact factor: 8.311

6.  Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.

Authors:  Stephanie L Sellers; Nadia Milad; Zoe White; Chris Pascoe; Rayleigh Chan; Geoffrey W Payne; Chun Seow; Fabio Rossi; Michael A Seidman; Pascal Bernatchez
Journal:  J Lipid Res       Date:  2017-11-25       Impact factor: 5.922

7.  Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis.

Authors:  Soomin Shin; Katharine A Walz; Angela S Archambault; Julia Sim; Bryan P Bollman; Jessica Koenigsknecht-Talboo; Anne H Cross; David M Holtzman; Gregory F Wu
Journal:  J Neuroimmunol       Date:  2014-03-29       Impact factor: 3.478

Review 8.  Impact of hyperlipidemia on alloimmunity.

Authors:  Jessamyn Bagley; Jin Yuan; John Iacomini
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

Review 9.  The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Hong-Liang Zhang; Jiang Wu; Jie Zhu
Journal:  Clin Dev Immunol       Date:  2010-05-31

10.  Identification and analysis of immune-related transcriptome in Asian seabass Lates calcarifer.

Authors:  Jun Hong Xia; Gen Hua Yue
Journal:  BMC Genomics       Date:  2010-06-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.